More clinical and real-world data is needed on how well and for how long COVID-19 vaccines are protective before any decisions should be made on offering a third or booster doses, Europe’s drug regulators said on Wednesday. Speaking at a news briefing on the coronavirus pandemic, the European Medicines Agency’s head of biological health threats and vaccines strategy Marco Cavaleri cautioned against making “premature” moves to deploy booster COVID-19 shots.

“We need to look into real-world evidence to give us the data we need to know when would be the right time to give the third dose. We need to have data that show in the field, either real-world evidence or clinical trials, that show what is the level of protection that is retained by the vaccines that we currently have,” he said.

• Orient Cables Eyes Rs 3,500 Crore Revenue By FY30
• Bangladesh Resumes Indian Wheat Purchases as Black Sea Disruptions Lift Prices
• Central Railway Recovers Rs 140 Crore In Ticket Fines
• Cosmic CRF Unit Bags Rs 25.94 Crore Combined Orders
• Arivihan in Talks to Raise Rs 96 Crore at Rs 570 Crore Valuation

The European Union has already begun ordering COVID-19 booster vaccines and Britain and the United States have also begun preparing plans to offer third doses before the winter. Asked about evidence so far on COVID-19 vaccine performance against a new variant that emerged in India, Cavaleri said EMA was monitoring the situation “very closely” and that data was “rather reassuring” for vaccines in use in the European Union.